573 related articles for article (PubMed ID: 24347663)
21. Prognostic utility of neutrophil gelatinase-associated lipocalin in predicting mortality and cardiovascular events in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
Lindberg S; Pedersen SH; Mogelvang R; Jensen JS; Flyvbjerg A; Galatius S; Magnusson NE
J Am Coll Cardiol; 2012 Jul; 60(4):339-45. PubMed ID: 22813613
[TBL] [Abstract][Full Text] [Related]
22. Plasma neutrophil gelatinase-associated lipocalin (NGAL) correlations with cystatin C, serum creatinine, and glomerular filtration rate in patients after heart and lung transplantation.
Szewczyk M; Wielkoszyński T; Zakliczyński M; Zembala M
Transplant Proc; 2009 Oct; 41(8):3242-3. PubMed ID: 19857721
[TBL] [Abstract][Full Text] [Related]
23. Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in patients with chronic heart failure and coronary artery disease.
Poniatowski B; Malyszko J; Bachorzewska-Gajewska H; Malyszko JS; Dobrzycki S
Kidney Blood Press Res; 2009; 32(2):77-80. PubMed ID: 19287180
[TBL] [Abstract][Full Text] [Related]
24. Neutrophil gelatinase--associated lipocalin predicts acute kidney injury in patients undergoing liver transplantation.
Portal AJ; McPhail MJ; Bruce M; Coltart I; Slack A; Sherwood R; Heaton ND; Shawcross D; Wendon JA; Heneghan MA
Liver Transpl; 2010 Nov; 16(11):1257-66. PubMed ID: 21031541
[TBL] [Abstract][Full Text] [Related]
25. The association between neutrophil gelatinase-associated lipocalin and clinical outcome in chronic heart failure: results from CORONA*.
Nymo SH; Ueland T; Askevold ET; Flo TH; Kjekshus J; Hulthe J; Wikstrand J; McMurray J; Van Veldhuisen DJ; Gullestad L; Aukrust P; Yndestad A
J Intern Med; 2012 May; 271(5):436-43. PubMed ID: 22211640
[TBL] [Abstract][Full Text] [Related]
26. Plasma neutrophil gelatinase-associated lipocalin as a potential predictor of adverse renal outcomes in immunoglobulin A nephropathy.
Park GY; Yu CH; Kim JS; Kang YJ; Kwon O; Choi JY; Cho JH; Kim CD; Kim YL; Park SH
Korean J Intern Med; 2015 May; 30(3):345-53. PubMed ID: 25995665
[TBL] [Abstract][Full Text] [Related]
27. Neutrophil gelatinase-associated lipocalin in the diagnosis of type 1 cardio-renal syndrome in the general ward.
Alvelos M; Pimentel R; Pinho E; Gomes A; Lourenço P; Teles MJ; Almeida P; Guimarães JT; Bettencourt P
Clin J Am Soc Nephrol; 2011 Mar; 6(3):476-81. PubMed ID: 21115620
[TBL] [Abstract][Full Text] [Related]
28. Increased plasma neutrophil gelatinase-associated lipocalin levels predict mortality in elderly patients with chronic heart failure.
Bolignano D; Basile G; Parisi P; Coppolino G; Nicocia G; Buemi M
Rejuvenation Res; 2009 Feb; 12(1):7-14. PubMed ID: 19196011
[TBL] [Abstract][Full Text] [Related]
29. Plasma neutrophil gelatinase-associated lipocalin predicts major adverse cardiovascular events after cardiac care unit discharge.
Ito M; Doi K; Takahashi M; Koyama K; Myojo M; Hosoya Y; Kiyosue A; Ando J; Noiri E; Yahagi N; Hirata Y; Komuro I
J Cardiol; 2016 Feb; 67(2):184-91. PubMed ID: 26228001
[TBL] [Abstract][Full Text] [Related]
30. High serum and urine neutrophil gelatinase-associated lipocalin levels are independent predictors of renal progression in patients with immunoglobulin A nephropathy.
Rhee H; Shin N; Shin MJ; Yang BY; Kim IY; Song SH; Lee DW; Lee SB; Kwak IS; Seong EY
Korean J Intern Med; 2015 May; 30(3):354-61. PubMed ID: 25995666
[TBL] [Abstract][Full Text] [Related]
31. Prognostic utility of plasma neutrophil gelatinase-associated lipocalin in patients with acute heart failure: the NGAL EvaLuation Along with B-type NaTriuretic Peptide in acutely decompensated heart failure (GALLANT) trial.
Maisel AS; Mueller C; Fitzgerald R; Brikhan R; Hiestand BC; Iqbal N; Clopton P; van Veldhuisen DJ
Eur J Heart Fail; 2011 Aug; 13(8):846-51. PubMed ID: 21791540
[TBL] [Abstract][Full Text] [Related]
32. Serum neutrophil gelatinase-associated lipocalin correlates with kidney function in heart allograft recipients.
Przybylowski P; Malyszko J; Malyszko JS
Transplant Proc; 2010 Jun; 42(5):1797-802. PubMed ID: 20620526
[TBL] [Abstract][Full Text] [Related]
33. Neutrophil gelatinase-associated lipocalin associated with irreversibility of pre-liver transplant kidney dysfunction.
Aberg F; Lempinen M; Hollmén M; Nordin A; Mäkisalo H; Isoniemi H
Clin Transplant; 2014 Aug; 28(8):869-76. PubMed ID: 24930480
[TBL] [Abstract][Full Text] [Related]
34. Prognostic impact of renal function in precapillary pulmonary hypertension.
Kaiser R; Seiler S; Held M; Bals R; Wilkens H
J Intern Med; 2014 Feb; 275(2):116-26. PubMed ID: 24011362
[TBL] [Abstract][Full Text] [Related]
35. Serum cystatin C and serum and urine NGAL in the kidney function assessment of patients with MGUS.
Stelmach-Goldys A; Czarkowska-Paczek B; Wyczalkowska-Tomasik A; Paczek L
Eur J Haematol; 2015 Feb; 94(2):162-8. PubMed ID: 25046079
[TBL] [Abstract][Full Text] [Related]
36. Clinical application of neutrophil gelatinase-associated lipocalin in the revised chronic kidney disease classification.
Xiang D; Zhang H; Bai J; Ma J; Li M; Gao J; Wang C
Int J Clin Exp Pathol; 2014; 7(10):7172-81. PubMed ID: 25400814
[TBL] [Abstract][Full Text] [Related]
37. Neutrophil gelatinase-associated lipocalin as a biomarker of renal impairment in patients with multiple myeloma.
Chae H; Ryu H; Cha K; Kim M; Kim Y; Min CK
Clin Lymphoma Myeloma Leuk; 2015 Jan; 15(1):35-40. PubMed ID: 25204517
[TBL] [Abstract][Full Text] [Related]
38. Neutrophil gelatinase-associated lipocalin predicts worsening of renal function in acute heart failure: methodological and clinical issues.
Mortara A; Bonadies M; Mazzetti S; Fracchioni I; Delfino P; Chioffi M; Bersano C; Specchia G
J Cardiovasc Med (Hagerstown); 2013 Sep; 14(9):629-34. PubMed ID: 23803723
[TBL] [Abstract][Full Text] [Related]
39. Neutrophil gelatinase-associated lipocalin: a novel marker of contrast nephropathy risk.
McCullough PA; Williams FJ; Stivers DN; Cannon L; Dixon S; Alexander P; Runyan D; David S
Am J Nephrol; 2012; 35(6):509-14. PubMed ID: 22627273
[TBL] [Abstract][Full Text] [Related]
40. Serum neutrophil gelatinase-associated lipocalin is associated with cardiovascular events in patients with chronic kidney disease.
Solak Y; Yilmaz MI; Siriopol D; Saglam M; Unal HU; Yaman H; Gok M; Cetinkaya H; Gaipov A; Eyileten T; Sari S; Yildirim AO; Tonbul HZ; Turk S; Covic A; Kanbay M
Int Urol Nephrol; 2015 Dec; 47(12):1993-2001. PubMed ID: 26498629
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
